menu
    • menu

    Find Aminolevulinic Acid HCl manufacturers, exporters & distributors on PharmaCompass

    Midas Aminolevulinic Acid HCl

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Synopsis

    Product SearchProduct Search

    Synopsis

    ACTIVE PHARMA INGREDIENTS

    10

    API Suppliers

    API Suppliers

    6

    USDMF

    US DMFs Filed

    0

    CEP/COS

    CEP/COS Certifications

    2

    JDMF

    JDMFs Filed

    0

    EU WC

    EU WC

    1

    KDMF

    KDMF

    4

    NDC API

    NDC API

    0

    VMF

    NDC API

    4

    Listed Suppliers

    Other Suppliers

    API REF. PRICE (USD/KG)

    $
    $ 31,474

    MARKET PLACE

    3

    API

    1

    FDF

    2INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    13

    FDF Dossiers

    FDF Dossiers

    3

    FDA Orange Book

    FDA (Orange Book)

    8

    Europe

    Europe

    2

    Canada

    Canada

    0

    Australia

    Australia

    0

    South Africa

    South Africa

    0

    Listed Dossiers

    Listed Dossiers

    18DRUGS IN DEVELOPMENT

    FDF Dossiers

    DRUG PRODUCT COMPOSITIONS

    REF. STANDARDS OR IMPURITIES

    0

    EDQM

    3

    USP

    0

    JP

    3

    Others

    PATENTS & EXCLUSIVITIES

    7

    US Patents

    1

    US Exclusivities

    0

    Health Canada Patents

    DIGITAL CONTENT

    1

    Data Compilation #PharmaFlow

    0

    Stock Recap #PipelineProspector

    0

    Weekly News Recap #Phispers

    16

    News #PharmaBuzz

    GLOBAL SALES INFORMATION

    US Medicaid

    196,105

    Annual Reports

    NA

    Finished Drug Prices

    Listed Dossiers

    26 RELATED EXCIPIENT COMPANIES

    56EXCIPIENTS BY APPLICATIONS

    Chemistry

    Click the arrow to open the dropdown
    read-moreClick the button for full data set
    read-moreClick the button for full data set
    Also known as: 5451-09-2, Aminolevulinic acid hydrochloride, Levulan, 5-amino-4-oxopentanoic acid hydrochloride, Levulan kerastick, 5-aminolevulinic acid hcl
    Molecular Formula
    C5H10ClNO3
    Molecular Weight
    167.59  g/mol
    InChI Key
    ZLHFONARZHCSET-UHFFFAOYSA-N
    FDA UNII
    V35KBM8JGR
    Aminolevulinic Acid HCl
    A compound produced from succinyl-CoA and GLYCINE as an intermediate in heme synthesis. It is used as a PHOTOCHEMOTHERAPY for actinic KERATOSIS.
    1 2D Structure

    Aminolevulinic Acid HCl

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    5-amino-4-oxopentanoic acid;hydrochloride
    2.1.2 InChI
    InChI=1S/C5H9NO3.ClH/c6-3-4(7)1-2-5(8)9;/h1-3,6H2,(H,8,9);1H
    2.1.3 InChI Key
    ZLHFONARZHCSET-UHFFFAOYSA-N
    2.1.4 Canonical SMILES
    C(CC(=O)O)C(=O)CN.Cl
    2.2 Other Identifiers
    2.2.1 UNII
    V35KBM8JGR
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. 5 Aminolaevulinate

    2. 5 Aminolevulinate

    3. 5-aminolaevulinate

    4. 5-aminolevulinate

    5. Acid Hydrochloride, Aminolevulinic

    6. Acid, Aminolevulinic

    7. Acid, Delta-aminolevulinic

    8. Aminolevulinic Acid

    9. Aminolevulinic Acid Hydrochloride

    10. Delta Aminolevulinic Acid

    11. Delta-aminolevulinic Acid

    12. Hydrochloride, Aminolevulinic Acid

    13. Levulan

    2.3.2 Depositor-Supplied Synonyms

    1. 5451-09-2

    2. Aminolevulinic Acid Hydrochloride

    3. Levulan

    4. 5-amino-4-oxopentanoic Acid Hydrochloride

    5. Levulan Kerastick

    6. 5-aminolevulinic Acid Hcl

    7. Gliolan

    8. Aminolevulinic Acid Hcl

    9. Ameluz

    10. Delta-aminolevulinic Acid Hydrochloride

    11. Mfcd00012869

    12. Alaglio

    13. Gleolan

    14. Alabel

    15. Pentanoic Acid, 5-amino-4-oxo-, Hydrochloride

    16. 5-aminolevulinic Acid, Hcl

    17. 5-aminolevulinic Acid (hydrochloride)

    18. 5-aminolevulinate Hydrochloride

    19. 5-ala

    20. Nsc-18509

    21. V35kbm8jgr

    22. 5-aminolevulinic Acid Hydrochloride Salt

    23. .delta.-aminolevulinic Acid Hydrochloride

    24. 5-amino-4-oxopentanoic Acid;hydrochloride

    25. Npc-07

    26. (4-carboxy-2-oxobutyl)azanium;chloride

    27. 5-amino-4-oxopentanoic Acid Hcl

    28. Aminolevulinic Acid Hydrochloride [usan]

    29. Ncgc00095111-01

    30. Dsstox_cid_25914

    31. Dsstox_rid_81222

    32. Dsstox_gsid_45914

    33. 5-amino-4-oxopentanoic Acid Hydrochloride;5-amino-4-oxopentanoic Acid

    34. Cas-5451-09-2

    35. 5-amino-levulinic Acid Hydrochloride

    36. 5-aminolevulinic Acid Hydrochloride, >=97.0% (at)

    37. Alacare

    38. Ala Hydrochloride

    39. Einecs 226-679-5

    40. Gleolan (tn)

    41. Levulan (tn)

    42. Ameluz (tn)

    43. Nsc 18509

    44. Ala Hcl

    45. Ala-pdt

    46. Levulinic Acid, 5-amino-, Hydrochloride

    47. Unii-v35kbm8jgr

    48. 5-amino-3-oxopentanoic Acid (hydrochloride)

    49. 5-aminolevulinic Acid.hcl

    50. Ala;5-ala

    51. Pentanoic Acid, Hydrochloride

    52. 5-amino-4-keto-valeric Acid

    53. Schembl192308

    54. Spectrum1504184

    55. Chembl1200582

    56. Dtxsid5045914

    57. Chebi:132969

    58. Hms1922f13

    59. Pd-p-506-a

    60. Pharmakon1600-01504184

    61. 5 Ala Hcl (trivial Name)

    62. Act05562

    63. Bcp02161

    64. Hy-n0305

    65. Nsc18509

    66. 5-amino Levulinic Acid Hydrochloride

    67. Tox21_111426

    68. Ccg-39079

    69. Nsc758687

    70. Akos015904495

    71. Aminolevulinic Acid Hcl [inci]

    72. Tox21_111426_1

    73. Ac-4252

    74. Bcp9000174

    75. Gs-3020

    76. Nsc-758687

    77. 4-carboxy-2-oxobutan-1-aminium Chloride

    78. 5-aminolevulinic Acid Hydrochloride, Gmp

    79. Ncgc00095111-02

    80. Ncgc00095111-03

    81. Ncgc00178086-03

    82. 5451-09-2 (hcl)

    83. Sy017972

    84. Db-005367

    85. 5-aminolevulinic Acid Hydrochloride, >=98%

    86. A0325

    87. Am20100341

    88. S2553

    89. Sw218068-2

    90. Aminolevulinic Acid Hydrochloride (jan/usan)

    91. A-6100

    92. A-6102

    93. A-6103

    94. A-6105

    95. Aminolevulinic Acid Hydrochloride [jan]

    96. D02908

    97. Aminolevulinic Acid Hydrochloride [mart.]

    98. 451a092

    99. Aminolevulinic Acid Hydrochloride [usp-rs]

    100. Aminolevulinic Acid Hydrochloride [who-dd]

    101. .delta.-aminolevulinic Acid Hydrochloride [mi]

    102. 5-aminolevulinic Acid Hydrochloride [ema Epar]

    103. Aminolevulinic Acid Hydrochloride [orange Book]

    104. Q27291473

    105. Aminolevulinic Acid Hydrochloride [usp Monograph]

    106. 0c1e43db-1221-4963-bfa4-18d3170000a4

    107. 5-aminolevulinic Acid Hydrochloride, Particle Size < 0.25 Mm

    108. Aminolevulinic Acid Hydrochloride Component Of Sonala001

    109. Aminolevulinic Acid Hydrochloride Component Of Sonala-001

    110. 5-aminolevulinic Acid Hydrochloride, Bioreagent, Suitable For Cell Culture, Powder, >=98%

    111. Aminolevulinic Acid Hcl; Aminolevulinic Acid Hydrochloride;ala; 5-ala;aminolevulinic Acid

    112. Aminolevulinic Acid Hydrochloride, United States Pharmacopeia (usp) Reference Standard

    2.4 Create Date
    2005-07-19
    3 Chemical and Physical Properties
    Molecular Weight 167.59 g/mol
    Molecular Formula C5H10ClNO3
    Hydrogen Bond Donor Count3
    Hydrogen Bond Acceptor Count4
    Rotatable Bond Count4
    Exact Mass167.0349209 g/mol
    Monoisotopic Mass167.0349209 g/mol
    Topological Polar Surface Area80.4 Ų
    Heavy Atom Count10
    Formal Charge0
    Complexity121
    Isotope Atom Count0
    Defined Atom Stereocenter Count0
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count2
    4 Drug and Medication Information
    4.1 Drug Information
    1 of 2  
    Drug NameLevulan
    PubMed HealthAminolevulinic Acid (On the skin)
    Drug ClassesPhotosensitizing Agent
    Active IngredientAminolevulinic acid hydrochloride
    Dosage FormSolution
    RouteTopical
    Strength20%
    Market StatusPrescription
    CompanyDusa

    2 of 2  
    Drug NameLevulan
    PubMed HealthAminolevulinic Acid (On the skin)
    Drug ClassesPhotosensitizing Agent
    Active IngredientAminolevulinic acid hydrochloride
    Dosage FormSolution
    RouteTopical
    Strength20%
    Market StatusPrescription
    CompanyDusa

    4.2 Drug Indication

    Treatment of actinic keratosis of mild to moderate severity on the face and scalp (Olsen grade 1 to 2; see section 5. 1) and of field cancer ization in adults.

    Treatment of superficial and/or nodular basal cell carcinoma unsuitable for surgical treatment due to possible treatment-related morbidity and/or poor cosmetic outcome in adults.

    Gliolan is indicated in adult patients for visualisation of malignant tissue during surgery for malignant glioma (World Health Organization grade III and IV).

    5 Pharmacology and Biochemistry
    5.1 MeSH Pharmacological Classification

    Photosensitizing Agents

    Drugs that are pharmacologically inactive but when exposed to ultraviolet radiation or sunlight are converted to their active metabolite to produce a beneficial reaction affecting the diseased tissue. These compounds can be administered topically or systemically and have been used therapeutically to treat psoriasis and various types of neoplasms. (See all compounds classified as Photosensitizing Agents.)

    5.2 FDA Pharmacological Classification
    5.2.1 Pharmacological Classes
    Optical Imaging Agent [EPC]; Porphyrin Precursor [EPC]; Porphyrinogens [CS]; Fluorescence Contrast Activity [MoA]; Porphyrin Precursor [EPC]
    5.3 ATC Code

    L01XD04

    L01XD04

    API SUPPLIERS

    read-more
    read-more

    01

    Midas Pharma

    Germany

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    TIDES Europe 2024
    Attending
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothMidas Pharma provides expertise in developing and supplying APIs, finished products, and intermediates.

    Contact Supplier Contact Supplier
    Flag Germany
    Virtual Booth Virtual Booth
    Digital Content Digital Content
    USDMF arrow-down Click Us! arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 29376

    Submission : 2015-05-27

    Status : Active

    Type : II

     CEP/COS JDMF EU-WC NDC KDMF VMF ASMF, CH... arrow-down
    ✖
    Available Reg Filing : ASMF, CH, TR
    AUDIT
    Midas Pharma

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Bachem AG

    Switzerland

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Bio-Europe 2024
    Gold Sponsor
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothBachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.

    Contact Supplier Contact Supplier
    Flag Switzerland
    Virtual Booth Virtual Booth
    Digital Content Digital Content
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 9972

    Submission : 1992-11-25

    Status : Active

    Type : II

     CEP/COS JDMF EU-WC NDC arrow-down
    ✖

    NDC Package Code : 51504-0005

    Start Marketing Date : 1992-11-25

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

     KDMF arrow-down
    ✖

    Registrant Name : Daewoong Pharmaceutical Co., Ltd.

    Registration Date : 2007-09-28

    Registration Number : 43-2-ND

    Manufacturer Name : Sochinaz SA

    Manufacturer Address : Route du Simplon 22 CH-1895 Vionnaz, Switzerland

     VMF Others AUDIT
    Bachem company banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Heraeus Holding

    Germany

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    SupplySide West 2024
    Not Confirmed
    arrow

    Heraeus Holding

    Germany

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    SupplySide West 2024
    Not Confirmed
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 24359

    Submission : 2010-11-12

    Status : Active

    Type : II

     CEP/COS JDMF arrow-down
    ✖

    Registration Number : 224MF10095

    Registrant's Address : Heraeusstr. 12-14; 63450 Hanau; Germany

    Initial Date of Registration : 2012-04-27

    Latest Date of Registration : --

     EU-WC NDC KDMF VMF Others AUDIT
    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Nippon Rikagaku Yakuhin

    Japan

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    SupplySide West 2024
    Not Confirmed
    arrow

    Nippon Rikagaku Yakuhin

    Japan

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    SupplySide West 2024
    Not Confirmed
    USDMF Inactive-api
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 23711

    Submission : 2010-04-06

    Status : Inactive

    Type : II

     CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    MEDAC GESELLSCHAFT FUR KLINISCHE S...

    Germany

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    SupplySide West 2024
    Not Confirmed
    arrow

    MEDAC GESELLSCHAFT FUR KLINISCHE S...

    Germany

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    SupplySide West 2024
    Not Confirmed
    USDMF Inactive-api
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 24562

    Submission : 2010-12-27

    Status : Inactive

    Type : II

     CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Juzen Chemical Corporation

    Japan

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    SupplySide West 2024
    Not Confirmed
    arrow

    Juzen Chemical Corporation

    Japan

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    SupplySide West 2024
    Not Confirmed
    USDMF Inactive-api
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 17844

    Submission : 2004-11-15

    Status : Inactive

    Type : II

     CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Jiangsu Lianhuan Pharmaceutical

    China

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    SupplySide West 2024
    Not Confirmed
    arrow

    08

    Guangzhou Tosun Pharmaceutical

    China

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    SupplySide West 2024
    Not Confirmed
    arrow

    09

    Biosynth AG

    Switzerland

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    SupplySide West 2024
    Not Confirmed
    arrow

    Biosynth AG

    Switzerland

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    SupplySide West 2024
    Not Confirmed
    USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    Nihon Rikagaku

    Japan

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    SupplySide West 2024
    Not Confirmed
    arrow

    Nihon Rikagaku

    Japan

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    SupplySide West 2024
    Not Confirmed
    USDMF CEP/COS JDMF arrow-down
    ✖

    Registration Number : 229MF10010

    Registrant's Address : 2-2 Nihonbashi Honcho 4-chome, Chuo-ku, Tokyo

    Initial Date of Registration : 2017-01-18

    Latest Date of Registration : --

     EU-WC NDC KDMF VMF Others AUDIT
    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    API Reference Price

    read-more
    read-more
    [{"dataSource":"API Import","activeIngredients":"","year":"2021","qtr":"Q4","strtotime":1637087400,"product":"5-AMINOLEVULINIC ACID HYDROCHLORIDE FOR BIOCHEMISTRY 1 PCS X500 MG","address":"GODREJ ONE, 8TH FLR, PIROJSHANAGAR, EASTERN EXPRESS HIGHWAY VIKHROLI-E","city":"MUMBAI","supplier":"MERCK GROUP","supplierCountry":"GERMANY","foreign_port":"NA","customer":"MERCK GROUP","customerCountry":"INDIA","quantity":"0.00","actualQuantity":"0.001","unit":"KGS","unitRateFc":"6693120","totalValueFC":"90","currency":"INR","unitRateINR":"6700480","date":"17-Nov-2021","totalValueINR":"6700.48","totalValueInUsd":"90","indian_port":"BOMBAY AIR","hs_no":"29225090","bill_no":"6282118","productDescription":"API","marketType":"REGULATED MARKET","country":"GERMANY","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"GODREJ ONE, 8TH FLR, PIROJSHANAGAR, EASTERN EXPRESS HIGHWAY VIKHROLI-E"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q1","strtotime":1642012200,"product":"5-AMINOLEVULINIC ACID HYDROCHLORIDE FOR BIOCHEMISTRY 2 PCS X2.5 G","address":"GODREJ ONE, 8TH FLR, PIROJSHANAGAR, EASTERN EXPRESS HIGHWAY VIKHROLI-E","city":"MUMBAI","supplier":"MERCK GROUP","supplierCountry":"GERMANY","foreign_port":"FRANKFURT\/MAIN INT\\'L","customer":"MERCK GROUP","customerCountry":"INDIA","quantity":"0.01","actualQuantity":"0.006","unit":"KGS","unitRateFc":"5182423.3","totalValueFC":"418","currency":"INR","unitRateINR":"5190196.7","date":"13-Jan-2022","totalValueINR":"31141.18","totalValueInUsd":"418","indian_port":"BOMBAY AIR","hs_no":"29225090","bill_no":"7070026","productDescription":"API","marketType":"REGULATED MARKET","country":"GERMANY","selfForZScoreResived":"Pharma Grade","supplierPort":"FRANKFURT\/MAIN INT\\'L","supplierAddress":"","customerAddress":"GODREJ ONE, 8TH FLR, PIROJSHANAGAR, EASTERN EXPRESS HIGHWAY VIKHROLI-E"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q1","strtotime":1645813800,"product":"5-AMINOLEVULINIC ACID HYDROCHLORIDE FOR BIOCHEMISTRY 1 PCS X500 MG","address":"GODREJ ONE, 8TH FLR, PIROJSHANAGAR, EASTERN EXPRESS HIGHWAY VIKHROLI-E","city":"MUMBAI","supplier":"MERCK GROUP","supplierCountry":"GERMANY","foreign_port":"NA","customer":"MERCK GROUP","customerCountry":"INDIA","quantity":"0.00","actualQuantity":"0.001","unit":"KGS","unitRateFc":"5689150","totalValueFC":"76","currency":"INR","unitRateINR":"5697680","date":"26-Feb-2022","totalValueINR":"5697.68","totalValueInUsd":"76","indian_port":"BOMBAY AIR","hs_no":"29225090","bill_no":"7653649","productDescription":"API","marketType":"REGULATED MARKET","country":"GERMANY","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"GODREJ ONE, 8TH FLR, PIROJSHANAGAR, EASTERN EXPRESS HIGHWAY VIKHROLI-E"}]
    17-Nov-2021
    26-Feb-2022
    KGS
    overview
    Loading...

    Average Price (USD/KGS)

    Number of Transactions

    Total Quantity (KGS)

    Total Value (USD)

    Quantity (KGS) & Unit rate (USD/KGS) over time

    API Imports and Exports

    Importing Country Total Quantity
    (KGS)    		 Average Price
    (USD/KGS)    		 Number of Transactions

    Upgrade, download data, analyse, strategize, subscribe with us contact

    Drugs in Development

    read-more
    read-more
    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Biofrontera Completes Database Lock in Ameluz® PDT Study for sBCC

    Details:

    Ameluz (5-aminolevulinic acid hydrochloride) is a topical gel that acts as a photosensitizing agent during photodynamic therapy. It is used primarily for the treatmentsuperficial basal cell carcinoma.


    Lead Product(s): Aminolevulinic Acid HCl

    Therapeutic Area: Oncology Brand Name: Ameluz

    Study Phase: Phase IIIProduct Type: Small molecule

    Sponsor: Not Applicable

    Deal Size: Not Applicable Upfront Cash: Not Applicable

    Deal Type: Not Applicable October 14, 2024

    blank

    01

    Biofrontera

    U.S.A
    arrow
    World Vaccine Congress
    Not Confirmed

    Biofrontera

    U.S.A
    arrow
    World Vaccine Congress
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Aminolevulinic Acid HCl

    Therapeutic Area : Oncology

    Highest Development Status : Phase III

    Partner/Sponsor/Collaborator : Not Applicable

    Deal Size : Not Applicable

    Deal Type : Not Applicable

    DEALS_DEV arrow-down

    Biofrontera Completes Database Lock in Ameluz® PDT Study for sBCC

    Details : Ameluz (5-aminolevulinic acid hydrochloride) is a topical gel that acts as a photosensitizing agent during photodynamic therapy. It is used primarily for the treatmentsuperficial basal cell carcinoma.

    Brand Name : Ameluz

    Molecule Type : Small molecule

    Upfront Cash : Not Applicable

    October 14, 2024

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    FDA OKs Triple-Tube Use of Ameluz Gel for Skin Cancer Treatment

    Details:

    Ameluz is the only PDT photosensitizer indicated by the FDA for both lesion-directed and field-directed treatment of Actinic Keratosis.


    Lead Product(s): Aminolevulinic Acid HCl

    Therapeutic Area: Dermatology Brand Name: Ameluz

    Study Phase: ApprovedProduct Type: Small molecule

    Sponsor: Not Applicable

    Deal Size: Not Applicable Upfront Cash: Not Applicable

    Deal Type: Not Applicable October 07, 2024

    blank

    02

    Biofrontera

    U.S.A
    arrow
    World Vaccine Congress
    Not Confirmed

    Biofrontera

    U.S.A
    arrow
    World Vaccine Congress
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Aminolevulinic Acid HCl

    Therapeutic Area : Dermatology

    Highest Development Status : Approved

    Partner/Sponsor/Collaborator : Not Applicable

    Deal Size : Not Applicable

    Deal Type : Not Applicable

    DEALS_DEV arrow-down

    FDA OKs Triple-Tube Use of Ameluz Gel for Skin Cancer Treatment

    Details : Ameluz is the only PDT photosensitizer indicated by the FDA for both lesion-directed and field-directed treatment of Actinic Keratosis.

    Brand Name : Ameluz

    Molecule Type : Small molecule

    Upfront Cash : Not Applicable

    October 07, 2024

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Deals
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Biofrontera Inc. Announces Closing Of Private Placement Of Up To $16.0 Million

    Details:

    The Company intends to fund ongoing activities related to expediting the development and approval of additional indications for Ameluz (aminolevulinic acid hydrochloride) to treat actinic keratoses.


    Lead Product(s): Aminolevulinic Acid HCl

    Therapeutic Area: Dermatology Brand Name: Ameluz

    Study Phase: ApprovedProduct Type: Small molecule

    Sponsor: Roth Capital Partners

    Deal Size: $16.0 million Upfront Cash: Undisclosed

    Deal Type: Private Placement January 23, 2024

    blank

    03

    Biofrontera

    U.S.A
    arrow
    World Vaccine Congress
    Not Confirmed

    Biofrontera

    U.S.A
    arrow
    World Vaccine Congress
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Aminolevulinic Acid HCl

    Therapeutic Area : Dermatology

    Highest Development Status : Approved

    Partner/Sponsor/Collaborator : Roth Capital Partners

    Deal Size : $16.0 million

    Deal Type : Private Placement

    DEALS_DEV arrow-down

    Biofrontera Inc. Announces Closing Of Private Placement Of Up To $16.0 Million

    Details : The Company intends to fund ongoing activities related to expediting the development and approval of additional indications for Ameluz (aminolevulinic acid hydrochloride) to treat actinic keratoses.

    Brand Name : Ameluz

    Molecule Type : Small molecule

    Upfront Cash : Undisclosed

    January 23, 2024

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    SonALAsense Announces Completion of First Cohort in Phase 2 Study of SONALA-001 Sonodynamic Therapy for Recurrent Glioblastoma

    Details:

    SONALA-001 (aminolevulinic acid) is a porphyrin precursor and optical imaging agent. The mechanism of action of aminolevulinic acid is as a fluorescence contrast activity.


    Lead Product(s): Aminolevulinic Acid HCl

    Therapeutic Area: Oncology Brand Name: SONALA-001

    Study Phase: Phase I/ Phase IIProduct Type: Small molecule

    Sponsor: Not Applicable

    Deal Size: Not Applicable Upfront Cash: Not Applicable

    Deal Type: Not Applicable March 08, 2023

    blank

    04

    SonALAsense

    U.S.A
    arrow
    World Vaccine Congress
    Not Confirmed

    SonALAsense

    U.S.A
    arrow
    World Vaccine Congress
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Aminolevulinic Acid HCl

    Therapeutic Area : Oncology

    Highest Development Status : Phase I/ Phase II

    Partner/Sponsor/Collaborator : Not Applicable

    Deal Size : Not Applicable

    Deal Type : Not Applicable

    DEALS_DEV arrow-down

    SonALAsense Announces Completion of First Cohort in Phase 2 Study of SONALA-001 Sonodynamic Therap...

    Details : SONALA-001 (aminolevulinic acid) is a porphyrin precursor and optical imaging agent. The mechanism of action of aminolevulinic acid is as a fluorescence contrast activity.

    Brand Name : SONALA-001

    Molecule Type : Small molecule

    Upfront Cash : Not Applicable

    March 08, 2023

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Biofrontera to Launch Phase 3 Clinical Study Evaluating Ameluz®-PDT for the Treatment of Actinic Keratosis on the Extremities, Neck and Trunk

    Details:

    AMELUZ® (aminolevulinic acid hydrochloride) topical gel, 10%, a porphyrin precursor, in combination with photodynamic therapy using BF-RhodoLED® lamp, is indicated for lesion-directed and field-directed treatment of actinic keratoses.


    Lead Product(s): Aminolevulinic Acid HCl

    Therapeutic Area: Dermatology Brand Name: Ameluz

    Study Phase: ApprovedProduct Type: Small molecule

    Sponsor: Not Applicable

    Deal Size: Not Applicable Upfront Cash: Not Applicable

    Deal Type: Not Applicable November 21, 2022

    blank

    05

    Biofrontera

    U.S.A
    arrow
    World Vaccine Congress
    Not Confirmed

    Biofrontera

    U.S.A
    arrow
    World Vaccine Congress
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Aminolevulinic Acid HCl

    Therapeutic Area : Dermatology

    Highest Development Status : Approved

    Partner/Sponsor/Collaborator : Not Applicable

    Deal Size : Not Applicable

    Deal Type : Not Applicable

    DEALS_DEV arrow-down

    Biofrontera to Launch Phase 3 Clinical Study Evaluating Ameluz®-PDT for the Treatment of Actinic ...

    Details : AMELUZ® (aminolevulinic acid hydrochloride) topical gel, 10%, a porphyrin precursor, in combination with photodynamic therapy using BF-RhodoLED® lamp, is indicated for lesion-directed and field-directed treatment of actinic keratoses.

    Brand Name : Ameluz

    Molecule Type : Small molecule

    Upfront Cash : Not Applicable

    November 21, 2022

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Biofrontera Inc. Announces Notice of Allowance for Nanoemulsion Composition-of-Matter U.S. Patent

    Details:

    AMELUZ (aminolevulinic acid hydrochloride) topical gel, 10%, a porphyrin precursor, in combination with photodynamic therapy using BF-RhodoLED® lamp, is indicated for the lesion-directed and field-directed treatment of actinic keratoses of mild-to-moderate severity.


    Lead Product(s): Aminolevulinic Acid HCl

    Therapeutic Area: Dermatology Brand Name: Ameluz

    Study Phase: ApprovedProduct Type: Small molecule

    Sponsor: Not Applicable

    Deal Size: Not Applicable Upfront Cash: Not Applicable

    Deal Type: Not Applicable September 06, 2022

    blank

    06

    Biofrontera

    U.S.A
    arrow
    World Vaccine Congress
    Not Confirmed

    Biofrontera

    U.S.A
    arrow
    World Vaccine Congress
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Aminolevulinic Acid HCl

    Therapeutic Area : Dermatology

    Highest Development Status : Approved

    Partner/Sponsor/Collaborator : Not Applicable

    Deal Size : Not Applicable

    Deal Type : Not Applicable

    DEALS_DEV arrow-down

    Biofrontera Inc. Announces Notice of Allowance for Nanoemulsion Composition-of-Matter U.S. Patent

    Details : AMELUZ (aminolevulinic acid hydrochloride) topical gel, 10%, a porphyrin precursor, in combination with photodynamic therapy using BF-RhodoLED® lamp, is indicated for the lesion-directed and field-directed treatment of actinic keratoses of mild-to-moder...

    Brand Name : Ameluz

    Molecule Type : Small molecule

    Upfront Cash : Not Applicable

    September 06, 2022

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    New Data and Forecasts for the U.S. Skin Cancer Market Strongly Support the Commercial Opportunity for Biofrontera's Ameluz

    Details:

    Ameluz (Aminolevulinic Acid Hydrochloride) is utilized along with photodynamic therapy (PDT) provided by the Company’s proprietary lamp devices to form Ameluz®-PDT.


    Lead Product(s): Aminolevulinic Acid HCl

    Therapeutic Area: Dermatology Brand Name: Ameluz

    Study Phase: ApprovedProduct Type: Small molecule

    Sponsor: Not Applicable

    Deal Size: Not Applicable Upfront Cash: Not Applicable

    Deal Type: Not Applicable May 24, 2022

    blank

    07

    Biofrontera

    U.S.A
    arrow
    World Vaccine Congress
    Not Confirmed

    Biofrontera

    U.S.A
    arrow
    World Vaccine Congress
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Aminolevulinic Acid HCl

    Therapeutic Area : Dermatology

    Highest Development Status : Approved

    Partner/Sponsor/Collaborator : Not Applicable

    Deal Size : Not Applicable

    Deal Type : Not Applicable

    DEALS_DEV arrow-down

    New Data and Forecasts for the U.S. Skin Cancer Market Strongly Support the Commercial Opportunity...

    Details : Ameluz (Aminolevulinic Acid Hydrochloride) is utilized along with photodynamic therapy (PDT) provided by the Company’s proprietary lamp devices to form Ameluz®-PDT.

    Brand Name : Ameluz

    Molecule Type : Small molecule

    Upfront Cash : Not Applicable

    May 24, 2022

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Deals
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Biofrontera Inc. Announces Closing of $9.4 Million Private Placement

    Details:

    The new funds will aid to expand the market presence and strategic position. Together with broadening the product label through three clinical trials running in parallel with licensing partner, this will unravel the enormous market potential Ameluz® has long term.


    Lead Product(s): Aminolevulinic Acid HCl

    Therapeutic Area: Dermatology Brand Name: Ameluz

    Study Phase: ApprovedProduct Type: Small molecule

    Sponsor: Roth Capital Partners

    Deal Size: $9.4 million Upfront Cash: Undisclosed

    Deal Type: Private Placement May 19, 2022

    blank

    08

    Biofrontera

    U.S.A
    arrow
    World Vaccine Congress
    Not Confirmed

    Biofrontera

    U.S.A
    arrow
    World Vaccine Congress
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Aminolevulinic Acid HCl

    Therapeutic Area : Dermatology

    Highest Development Status : Approved

    Partner/Sponsor/Collaborator : Roth Capital Partners

    Deal Size : $9.4 million

    Deal Type : Private Placement

    DEALS_DEV arrow-down

    Biofrontera Inc. Announces Closing of $9.4 Million Private Placement

    Details : The new funds will aid to expand the market presence and strategic position. Together with broadening the product label through three clinical trials running in parallel with licensing partner, this will unravel the enormous market potential Ameluz® has...

    Brand Name : Ameluz

    Molecule Type : Small molecule

    Upfront Cash : Undisclosed

    May 19, 2022

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Biofrontera Launches New Patient-Focused Websites for Ameluz® and Xepi®

    Details:

    AMELUZ (aminolevulinic acid hydrochloride) topical gel, a porphyrin precursor, in combination with photodynamic therapy using BF-RhodoLED® lamp, is indicated for lesion-directed and field-directed treatment of actinic keratoses of mild-to-moderate severity on face and scalp.


    Lead Product(s): Aminolevulinic Acid HCl

    Therapeutic Area: Dermatology Brand Name: Ameluz

    Study Phase: ApprovedProduct Type: Small molecule

    Sponsor: Not Applicable

    Deal Size: Not Applicable Upfront Cash: Not Applicable

    Deal Type: Not Applicable April 21, 2022

    blank

    09

    Biofrontera

    U.S.A
    arrow
    World Vaccine Congress
    Not Confirmed

    Biofrontera

    U.S.A
    arrow
    World Vaccine Congress
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Aminolevulinic Acid HCl

    Therapeutic Area : Dermatology

    Highest Development Status : Approved

    Partner/Sponsor/Collaborator : Not Applicable

    Deal Size : Not Applicable

    Deal Type : Not Applicable

    DEALS_DEV arrow-down

    Biofrontera Launches New Patient-Focused Websites for Ameluz® and Xepi®

    Details : AMELUZ (aminolevulinic acid hydrochloride) topical gel, a porphyrin precursor, in combination with photodynamic therapy using BF-RhodoLED® lamp, is indicated for lesion-directed and field-directed treatment of actinic keratoses of mild-to-moderate sever...

    Brand Name : Ameluz

    Molecule Type : Small molecule

    Upfront Cash : Not Applicable

    April 21, 2022

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Biofrontera to Showcase Actinic Keratoses and Impetigo Treatments at the 2022 American Academy of Dermatology Annual Meeting

    Details:

    Ameluz® is Biofrontera’s first FDA-approved flagship prescription drug is used in combination with the RhodoLED® lamp series for the treatment of Actinic Keratoses, and the topical antibiotic drug Xepi®.


    Lead Product(s): Aminolevulinic Acid HCl

    Therapeutic Area: Dermatology Brand Name: Ameluz

    Study Phase: ApprovedProduct Type: Small molecule

    Sponsor: Not Applicable

    Deal Size: Not Applicable Upfront Cash: Not Applicable

    Deal Type: Not Applicable March 17, 2022

    blank

    10

    Biofrontera

    U.S.A
    arrow
    World Vaccine Congress
    Not Confirmed

    Biofrontera

    U.S.A
    arrow
    World Vaccine Congress
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Aminolevulinic Acid HCl

    Therapeutic Area : Dermatology

    Highest Development Status : Approved

    Partner/Sponsor/Collaborator : Not Applicable

    Deal Size : Not Applicable

    Deal Type : Not Applicable

    DEALS_DEV arrow-down

    Biofrontera to Showcase Actinic Keratoses and Impetigo Treatments at the 2022 American Academy of ...

    Details : Ameluz® is Biofrontera’s first FDA-approved flagship prescription drug is used in combination with the RhodoLED® lamp series for the treatment of Actinic Keratoses, and the topical antibiotic drug Xepi®.

    Brand Name : Ameluz

    Molecule Type : Small molecule

    Upfront Cash : Not Applicable

    March 17, 2022

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    INTERMEDIATES SUPPLIERS

    read-more
    read-more

    01

    Bhushilpa Chemicals

    India
    SupplySide West 2024
    Not Confirmed
    arrow

    Bhushilpa Chemicals

    India
    SupplySide West 2024
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    ETHYL SUCCINYL CHLORIDE

    CAS Number : 14794-31-1

    End Use API : Aminolevulinic Acid HCl

    About The Company : Bhushilpa Chemicals was set up in 2001 with a vision to develop, manufacture and market specialty chemicals and drug intermediates through implementation of qu...

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Bhushilpa Chemicals

    India
    SupplySide West 2024
    Not Confirmed
    arrow

    Bhushilpa Chemicals

    India
    SupplySide West 2024
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    METHYL SUCCINYL CHLORIDE

    CAS Number : 1490-25-1

    End Use API : Aminolevulinic Acid HCl

    About The Company : Bhushilpa Chemicals was set up in 2001 with a vision to develop, manufacture and market specialty chemicals and drug intermediates through implementation of qu...

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    FDF Dossiers

    read-more
    read-more

    01

    Biofrontera

    U.S.A
    SupplySide West 2024
    Not Confirmed
    arrow

    Biofrontera

    U.S.A
    arrow
    SupplySide West 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info :

    Registration Country : Sweden

    aminolevulinic acid hydrochloride

    Brand Name : Ameluz

    Dosage Form : GEL

    Dosage Strength : 78 MG / G

    Packaging :

    Approval Date :

    Application Number :

    Regulatory Info :

    Registration Country : Sweden

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    DUSA Pharmaceuticals, Inc.

    U.S.A
    SupplySide West 2024
    Not Confirmed
    arrow

    DUSA Pharmaceuticals, Inc.

    U.S.A
    arrow
    SupplySide West 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Prescription

    Registration Country : Canada

    AMINOLEVULINIC ACID HYDROCHLORIDE

    Brand Name : LEVULAN KERASTICK

    Dosage Form : POWDER FOR SOLUTION

    Dosage Strength : 20%

    Packaging : 1.5ML

    Approval Date :

    Application Number : 2243933

    Regulatory Info : Prescription

    Registration Country : Canada

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Galderma

    Switzerland
    SupplySide West 2024
    Not Confirmed
    arrow

    Galderma

    Switzerland
    arrow
    SupplySide West 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Switzerland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info :

    Registration Country : Sweden

    aminolevulinic acid hydrochloride

    Brand Name : Alacare

    Dosage Form : MEDICAL PATCH

    Dosage Strength : 8 MG

    Packaging :

    Approval Date :

    Application Number :

    Regulatory Info :

    Registration Country : Sweden

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Gebro Pharma

    Austria
    SupplySide West 2024
    Not Confirmed
    arrow

    Gebro Pharma

    Austria
    arrow
    SupplySide West 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Austria
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info :

    Registration Country : Switzerland

    Aminolaevulinatis hydrochloridum

    Brand Name : Alacare

    Dosage Form : Pfl

    Dosage Strength : 8mg

    Packaging :

    Approval Date :

    Application Number :

    Regulatory Info :

    Registration Country : Switzerland

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Gebro Pharma

    Austria
    SupplySide West 2024
    Not Confirmed
    arrow

    Gebro Pharma

    Austria
    arrow
    SupplySide West 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Austria
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info :

    Registration Country : Switzerland

    Aminolaevulinatis hydrochloridum

    Brand Name : Alacare

    Dosage Form : Pfl

    Dosage Strength : 8mg

    Packaging :

    Approval Date :

    Application Number :

    Regulatory Info :

    Registration Country : Switzerland

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Louis Widmer

    Switzerland
    SupplySide West 2024
    Not Confirmed
    arrow

    Louis Widmer

    Switzerland
    arrow
    SupplySide West 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Switzerland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info :

    Registration Country : Switzerland

    Acidum aminolevulinicum

    Brand Name : Ameluz

    Dosage Form : Gel

    Dosage Strength : 78mg/g

    Packaging :

    Approval Date :

    Application Number :

    Regulatory Info :

    Registration Country : Switzerland

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    NX Development Corp

    U.S.A
    SupplySide West 2024
    Not Confirmed
    arrow

    NX Development Corp

    U.S.A
    arrow
    SupplySide West 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    AMINOLEVULINIC ACID HYDROCHLORIDE

    Brand Name : GLEOLAN

    Dosage Form : FOR SOLUTION;ORAL

    Dosage Strength : 1.5GM/VIAL

    Packaging :

    Approval Date : 2017-06-06

    Application Number : 208630

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    Sun Pharmaceutical Industries Limit...

    India
    SupplySide West 2024
    Not Confirmed
    arrow

    Sun Pharmaceutical Industries Limit...

    India
    arrow
    SupplySide West 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    AMINOLEVULINIC ACID HYDROCHLORIDE

    Brand Name : LEVULAN

    Dosage Form : SOLUTION;TOPICAL

    Dosage Strength : 20%

    Packaging :

    Approval Date : 1999-12-03

    Application Number : 20965

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    Country
    SupplySide West 2024
    Not Confirmed
    arrow

    Country
    arrow
    SupplySide West 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Country
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info :

    Registration Country : Sweden

    aminolevulinic acid hydrochloride

    Brand Name : Gliolan

    Dosage Form : POWDER FOR ORAL SOLUTION

    Dosage Strength : 30 MG / ML

    Packaging :

    Approval Date :

    Application Number :

    Regulatory Info :

    Registration Country : Sweden

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    Country
    SupplySide West 2024
    Not Confirmed
    arrow

    Country
    arrow
    SupplySide West 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Country
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info :

    Registration Country : Norway

    Aminolevulinic Acid

    Brand Name : Gliolan

    Dosage Form : Powder for potion, resolution

    Dosage Strength : 30 mg/ml

    Packaging : Hood glass

    Approval Date :

    Application Number :

    Regulatory Info :

    Registration Country : Norway

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    FDA Orange Book

    read-more
    read-more

    01

    BIOFRONTERA

    U.S.A
    Saudi International Expo
    Not Confirmed
    arrow

    BIOFRONTERA

    U.S.A
    arrow
    Saudi International Expo
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : Yes

    TE Code :

    AMINOLEVULINIC ACID HYDROCHLORIDE

    Brand Name : AMELUZ

    Dosage Form : GEL;TOPICAL

    Dosage Strength : 10%

    Approval Date : 2016-05-10

    Application Number : 208081

    RX/OTC/DISCN : RX

    RLD : Yes

    TE Code :

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    NXDC

    U.S.A
    Saudi International Expo
    Not Confirmed
    arrow

    NXDC

    U.S.A
    arrow
    Saudi International Expo
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : Yes

    TE Code :

    AMINOLEVULINIC ACID HYDROCHLORIDE

    Brand Name : GLEOLAN

    Dosage Form : FOR SOLUTION;ORAL

    Dosage Strength : 1.5GM/VIAL

    Approval Date : 2017-06-06

    Application Number : 208630

    RX/OTC/DISCN : RX

    RLD : Yes

    TE Code :

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    SUN PHARM INDS INC

    India
    Saudi International Expo
    Not Confirmed
    arrow

    SUN PHARM INDS INC

    India
    arrow
    Saudi International Expo
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : Yes

    TE Code :

    AMINOLEVULINIC ACID HYDROCHLORIDE

    Brand Name : LEVULAN

    Dosage Form : SOLUTION;TOPICAL

    Dosage Strength : 20%

    Approval Date : 1999-12-03

    Application Number : 20965

    RX/OTC/DISCN : RX

    RLD : Yes

    TE Code :

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    Related Excipient Companies

    Upload your portfolio for free, ask us

    Excipients by Applications

    Click here to find the perfect excipient manufacturers by their capabilities

    Solubilizers

    read-more
    read-more

    Topical

    read-more
    read-more

    Parenteral

    read-more
    read-more

    Thickeners and Stabilizers

    read-more
    read-more

    Emulsifying Agents

    read-more
    read-more

    Film Formers & Plasticizers

    read-more
    read-more

    Rheology Modifiers

    read-more
    read-more

    Surfactant & Foaming Agents

    read-more
    read-more

    API Stability Enhancers

    read-more
    read-more

    Controlled & Modified Release

    read-more
    read-more

    Direct Compression

    read-more
    read-more

    Co-Processed Excipients

    read-more
    read-more

    Coating Systems & Additives

    read-more
    read-more

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    DATA COMPILATION #PharmaFlow

    read-more
    read-more

    NEWS #PharmaBuzz

    read-more
    read-more

    Global Sales Information

    Do you need Business Intel? Ask us

    Market Place

    Do you need sourcing support? Ask us

    Patents & EXCLUSIVITIES

    Check the patents & exclusivity for this product

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    USP

    read-more
    read-more

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search